Literature DB >> 20679688

[Use of adipose tissue as a source of mesenchymal stem cells].

Katarzyna Jezierska-Woźniak1, Dorota Nosarzewska, Anna Tutas, Anita Mikołajczyk, Michał Okliński, Marek Kajetan Jurkowski.   

Abstract

Enormous expectations are associated with stem cells with regard to cell therapy and tissue engineering. Stem cells have unlimited potential for self-renewal and develop into various cell types. For the mesodermal tissue engineering such a source of cells is the bone marrow stroma. However, isolation of the bone marrow requires general or spinal anesthesia and yields low number of mesodermal stem cells (MSCs) upon processing (1 MSC per 105 adherent stromal cells). An alternative source of autologous stem cells seems to be, apart from bone marrow: periosteum, muscular tissue or synovial membrane and adipose tissue. The adipose tissue is derived from the embryonic mesenchyme, contains a large number of stromal stem cells and is relatively easy to obtain in large quantities. It covers a widespread area of human body, and can be classified as white and brown adipose tissue in terms of location and function. Specimens of the adipose tissue are usually obtained from elective, laparoscopic or liposuction surgeries. Stromal stem cells, isolated from this tissue, exhibit characteristics common to mesodermal tissues, including: adherence to plastic, formation of fibroblastic- like colonies, extensive proliferative capacity, ability to differentiate into several mesodermal lineages (including bone, cartilage, muscle and fat), and expression of several common cell surface antigens. Recent evidence suggest that these cells can also form non-mesodermal tissues--neuron-like cells. The aim of this publication is to describe the application of the adipose tissue as a source of mesenchymal stem cells based on current literature data.

Entities:  

Mesh:

Year:  2010        PMID: 20679688

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  6 in total

1.  Phenotypic Characterization of Adherent Cells Population CD34+ CD90+ CD105+ Derived from Wharton's Jelly.

Authors:  Irena Walecka; Paulina Gil-Kulik; Arkadiusz Krzyżanowski; Marcin Czop; Dariusz Galkowski; Jolanta Karwat; Piotr Chomik; Małgorzata Świstowska; Anna Kwaśniewska; Anna Bogucka-Kocka; Janusz Kocki
Journal:  Med Sci Monit       Date:  2017-04-19

Review 2.  Treatment of Articular Cartilage Defects: Focus on Tissue Engineering.

Authors:  Beata Żylińska; Piotr Silmanowicz; Aleksandra Sobczyńska-Rak; Łukasz Jarosz; Tomasz Szponder
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

3.  Human adipose and synovial mesenchymal stem cells improve osteoarthritis in rats by reducing chondrocyte reactive oxygen species and inhibiting inflammatory response.

Authors:  Xunzhi Liu; Yaqing Liu; Huabin He; Weiwei Xiang; Cheng He
Journal:  J Clin Lab Anal       Date:  2022-03-21       Impact factor: 3.124

4.  Biochanin a promotes osteogenic but inhibits adipogenic differentiation: evidence with primary adipose-derived stem cells.

Authors:  Shu-Jem Su; Yao-Tsung Yeh; Shu-Hui Su; Kee-Lung Chang; Huey-Wen Shyu; Kuan-Ming Chen; Hua Yeh
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-16       Impact factor: 2.629

Review 5.  Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?

Authors:  Michela Mocchi; Silvia Dotti; Maurizio Del Bue; Riccardo Villa; Elia Bari; Sara Perteghella; Maria Luisa Torre; Stefano Grolli
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

Review 6.  Adipose tissue-derived stem cells show considerable promise for regenerative medicine applications.

Authors:  Izabela Harasymiak-Krzyżanowska; Alicja Niedojadło; Jolanta Karwat; Lidia Kotuła; Paulina Gil-Kulik; Magdalena Sawiuk; Janusz Kocki
Journal:  Cell Mol Biol Lett       Date:  2013-08-14       Impact factor: 5.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.